Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Open accessAbstract
Gut microbiota of patients with Parkinson's disease and healthy volunteers was analyzed by the method of high throughput 16S rRNA sequencing of bacterial genomes. In patients with Parkinson's diseases, changes in the content of 9 genera and 15 species of microorganisms were revealed: reduced content of Dorea, Bacteroides, Prevotella, Faecalibacterium, Bacteroides massiliensis, Stoquefichus massiliensis, Bacteroides coprocola, Blautia glucerasea, Dorea longicatena, Bacteroides dorei, Bacteroides plebeus, Prevotella copri, Coprococcus eutactus, and Ruminococcus callidus, and increased content of Christensenella, Catabacter, Lactobacillus, Oscillospira, Bifidobacterium, Christensenella minuta, Catabacter hongkongensis, Lactobacillus mucosae, Ruminococcus bromii, and Papillibacter cinnamivorans. This microbiological pattern of gut microflora can trigger local inflammation followed by aggregation of α-synuclein and generation of Lewy bodies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The results reported by Petrov et al. and our research consistently showed that the abundance of Bifidobacterium in PD is increased.
“the results reported by Petrov et al. [37] and our research consistently showed that the abundance of Bifidobacterium in PD is increased.”
From Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota (2021) · cites this paper as [37]
Prevotella has been reported to be correlated negatively with PD and autism spectrum disorder (ASD).
“Prevotella has been reported to be correlated negatively with PD [37] and autism spectrum disorder (ASD) [38].”
From Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota (2021) · cites this paper as [37]
PD patients harbor an intestinal flora depleted in SCFA (mainly butyrate)-producing bacteria, including taxa from Lachnospiraceae and Faecalibacterium prausnitzii, which have known anti-inflammatory properties.
“Remarkably, PD patients harbored an intestinal flora depleted in SCFAs (mainly butyrate)-producing bacteria, like taxa from Lachnospiraceae family (175, 177–179), and Faecalibacterium prausnitzii (175, 180), those with known anti-inflammatory properties.”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [179]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 14 · Cited by 487
Research works printed but not linked: 56
- Barry G., Mattick J. S. The role of regulatory RNA in cognitive evolution //Trends in cognitive sciences. -2012. -Т. 16. -№. 10. -С. 497-503. doi: 10.1016/j.tics.2012.08.007. · DOI
- Berstad K., Berstad J. E. R. Parkinson's disease; the hibernating spore hypothesis //Medical hypotheses. -2017. -Т. 104. -С. 48-53. doi: 10.1016/j.mehy.2017.05.022. · DOI
- Bhattarai Y. et al. Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production //American Journal of Physiology-Gastrointestinal and Liver Physiology. -2017. -Т. 313. -№.
- Bien-Ly N., Watts R. J. The Blood-Brain Barrier's Gut Check //Science translational medicine. -2014. -Т. 6. -№. 263. -С. 263fs46-263fs46. doi: 10.1126/scitranslmed.aaa2543 · DOI
- Borg I., Groenen P. J. F. Modern multidimensional scaling: Theory and applications. -Springer Science & Business Media, 2005. ISBN 0-387-94845-7
- Braniste V. et al. The gut microbiota influences blood-brain barrier permeability in mice //Science translational medicine. -2014. -Т. 6. -№. 263. -С. 263ra158- 263ra158. doi:10.1126/scitranslmed.3009759. · DOI · Paper page
- Brooks G. et al. Jawetz Melnick&Adelbergs Medical Microbiology 26/E. - McGraw Hill Professional, 2012. ISBN 71815783
- Brüssow H. Turning the inside out: the microbiology of atopic dermatitis //Environmental microbiology. -2016. -Т. 18. -№. 7. -С. 2089-2102. doi: 10.1111/1462-2920.13050. · DOI
- Chao A. Nonparametric estimation of the number of classes in a population //Scandinavian Journal of statistics. -1984. -С. 265-270.
- Charlson E. S. et al. Topographical continuity of bacterial populations in the healthy human respiratory tract //American journal of respiratory and critical care medicine. - 2011. -Т. 184. -№. 8. -С. 957-963. doi: 10.1164/rccm.201104-0655OC · DOI · Paper page
- Cox P. A., Kostrzewa R. M., Guillemin G. J. BMAA and neurodegenerative illness //Neurotoxicity research. -2018. -Т. 33. -№. 1. -С. 178-183. doi: 10.1007/s12640- 017-9753-6 · DOI
- Craven M. et al. Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease //PLoS One. -2012. -Т. 7. -№. 7. -С. E41594. doi: 10.1007/s12640-017-9753-6 · DOI
- Deng H., Wang P., Jankovic J. The genetics of Parkinson disease //Ageing research reviews. -2018. -Т. 42. -С. 72-85. doi: 10.1016/j.arr.2017.12.007 · DOI · Paper page
- Dewhirst F. E. et al. The human oral microbiome //Journal of bacteriology. -2010.
- Dreno B. et al. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne //Experimental dermatology. -2017. -Т. 26. -№. 9. -С. 798-803. doi: 10.1111/exd.13296 · DOI
- Fernando M. R. et al. Butyrate enhances antibacterial effects while suppressing other features of alternative activation in IL-4-induced macrophages //American Journal of Physiology-Gastrointestinal and Liver Physiology. -2016. -Т. 310. -№.
- Forsythe P., Kunze W. A. Voices from within: gut microbes and the CNS //Cellular and molecular life sciences. -2013. -Т. 70. -№. 1. -С. 55-69. doi: 10.1007/s00018- 012-1028-z 100) · DOI
- Gaig C., Tolosa E. When does Parkinson's disease begin? //Movement Disorders. - 2009. -Т. 24. -№. S2. -С. 656-664. doi:10.1002/mds.22672 105 · DOI
- Goldstein D. S. et al. Cardiac sympathetic denervation in Parkinson disease //Annals of internal medicine. -2000. -Т. 133. -№. 5. -С. 338-347. 109
- Hague K. et al. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature //Acta neuropathologica. -1997. -Т. 94. -№. 2. - С. 192-196. 115
- Hamer H. M. et al. The role of butyrate on colonic function //Alimentary pharmacology & therapeutics. -2008. -Т. 27. -№. 2. -С. 104-119. doi:10.1111/j.1365-2036.2007.03562.x 118 · DOI
- D. J., Yu K. Idiot's Bayes-not so stupid after all? //International statistical review. -2001. -Т. 69. -№. 3. -С. 385-398. doi: 10.1111/j.1751- 5823.2001.tb00465.x 119 · DOI
- Hawkes C. H., Del Tredici K., Braak H. A timeline for Parkinson's disease //Parkinsonism & related disorders. -2010. -Т. 16. -№. 2. -С. 79-84. doi: 10.1016/j.parkreldis.2009.08.007. 123 · DOI
- Heckman M. G. et al. Parkinson's disease susceptibility variants and severity of Lewy body pathology //Parkinsonism & related disorders. -2017. -Т. 44. -С. 79-84. doi: 10.1016/j.parkreldis.2017.09.009 124 · DOI
- Hegarty S. V., Sullivan A. M., O'Keeffe G. W. The Epigenome as a therapeutic target for Parkinson's disease //Neural regeneration research. -2016. -Т. 11. -№. 11. - С. 1735. doi:10.4103/1673-5374.194803. · DOI
- Heijtz R. D. et al. Normal gut microbiota modulates brain development and behavior //Proceedings of the National Academy of Sciences. -2011. -Т. 108. -№. 7
- Holzer P., Farzi A. Neuropeptides and the microbiota-gut-brain axis //Microbial endocrinology: the microbiota-gut-brain axis in health and disease. -Springer, New York, NY, 2014. -С. 195-219. doi:10.1007/978-1-4939-0897-4_9 133 · DOI
- Hotelling H. Analysis of a complex of statistical variables into principal components //Journal of educational psychology. -1933. -Т. 24. -№. 6. -С. 417. 136
- Imhann F. et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease //Gut. -2016. -С. Gutjnl- 2016-312135. doi: 10.1136/gutjnl-2016-312135 139 · DOI
- Jin H. et al. Histone Hyperacetylation Up-regulates Protein Kinase Cδ in Dopaminergic Neurons to Induce Cell Death RELEVANCE TO EPIGENETIC MECHANISMS OF NEURODEGENERATION IN PARKINSON DISEASE //Journal of Biological Chemistry. -2014. -Т. 289. -№. 50. -С. 34743-34767. doi:10.1074/jbc.M114.576702. 145 · DOI
- Jumas-Bilak E., Marchandin H. The phylum synergistetes //The Prokaryotes. - Springer Berlin Heidelberg, 2014. -С. 931-954. ISBN 978-3-642-38954-2. doi: 10.1007/978-3-642-38954-2_384 146 · DOI
- Kramer P., Bressan P. Humans as superorganisms: How microbes, viruses, imprinted genes, and other selfish entities shape our behavior //Perspectives on Psychological Science. -2015. -Т. 10. -№. 4. -С. 464-481. doi: 10.1177/1745691615583131. 157 · DOI
- Kuhn M. et al. Caret package //Journal of statistical software. -2008. -Т. 28. - №. 5. -С. 1-26. 158
- Liu B. et al. Vagotomy and Parkinson disease A Swedish register-based matched- cohort study //Neurology. -2017. -Т. 88. -№. 21. -С. 1996-2002. doi:10.1212/WNL.0000000000003961 175 · DOI
- Magliacane S. et al. Causal transfer learning //arXiv preprint arXiv:1707.06422. - 2017. 182 · arXiv
- Meuric V. et al. Signature of microbial dysbiosis in periodontitis //Applied and environmental microbiology. -2017. -Т. 83. -№. 14. -С. E00462-17. doi: 10.1128/AEM.00462-17. 190 · DOI
- Montiel-Castro A. J. et al. The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality //Frontiers in integrative neuroscience. -2013. -Т. 7. - С. 70. doi: 10.3389/fnint.2013.00070 197 · DOI
- Müller D. B. et al. The plant microbiota: systems-level insights and perspectives //annual review of genetics. -2016. -Т. 50. -С. 211-234. doi:10.1146/annurev-genet- 120215-034952 200 · DOI
- Murray A. E. et al. Microbiome composition and diversity of the ice-dwelling sea anemone, Edwardsiella andrillae //Integrative and comparative biology. -2016. -Т. 56. -№. 4. -С. 542-555. doi: 10.1093/icb/icw095. 202 · DOI
- Nishiyama K. et al. Bifidobacterium bifidum Extracellular Sialidase Enhances 2017. -Т. 8. -№. 5. -С. E00928-17. doi:10.1128/mBio.00928-17 206 · DOI
- Parkinson J.An essay on the shaking palsy. 1817. Переиздано в Parkinson J. An essay on the shaking palsy //The Journal of neuropsychiatry and clinical neurosciences. -2002. -Т. 14. -№. 2. -С. 223-236. 210
- Rutherford S. T., Bassler B. L. Bacterial quorum sensing: its role in virulence and possibilities for its control //Cold Spring Harbor perspectives in medicine. -2012. -Т. 2. -№. 11. -С. A012427. doi: 10.1101/cshperspect.a012427 234 · DOI
- Saedisomeolia A., Ashoori M. Riboflavin in Human Health: A Review of Current Evidences //Advances in food and nutrition research. -Academic Press, 2018. -Т. 83. -С. 57-81. doi: 10.1016/bs.afnr.2017.11.002 235 · DOI
- Saint-Georges-Chaumet Y. et al. Targeting microbiota-mitochondria inter-talk: Microbiota control mitochondria metabolism //Cellular and Molecular Biology. -2015. -Т. 61. -№. 4. -С. 121-124. doi : 10.14715/cmb/2015.61.4.20 236 · DOI
- Shen C. H. et al. Association between tuberculosis and Parkinson disease: a nationwide, population-based cohort study //Medicine. -2016. -Т. 95. -№. 8. doi:10.1097/MD.0000000000002883. 250 · DOI
- Stiemsma L. T. et al. The hygiene hypothesis: current perspectives and future therapies //ImmunoTargets and therapy. -2015. -Т. 4. -С. 143. doi: 10.2147/ITT.S61528 260) · DOI
- Stilling R. M. et al. Friends with social benefits: host-microbe interactions as a driver of brain evolution and development? //Frontiers in cellular and infection microbiology. -2014. -Т. 4. -С. 147. doi: 10.3389/fcimb.2014.00147 261 · DOI
- Sullivan A. et al. The microbiome and the pathophysiology of asthma //Respiratory research. -2016. -Т. 17. -№. 1. -С. 163. doi: 10.1186/s12931-016- 0479-4 264 · DOI
- N. S. Regulatory peptides of the gut and brain //Canadian Journal of Surgery. -1983. -Т. 26. -№. 3. -С. 211-3, 228. 270
- Velázquez O. C., Lederer H. M., Rombeau J. L. Butyrate and the colonocyte //Dietary fiber in health and disease. -Springer, Boston, MA, 1997. -С. 123-134. 280
- Villanueva R. Neurobiology of major depressive disorder //Neural plasticity. - 2013. -Т. 2013. doi: 10.1155/2013/873278 281 · DOI
- Visanji N. P. et al. The prion hypothesis in Parkinson's disease: Braak to the future //Acta neuropathologica communications. -2013. -Т. 1. -№. 1. -С. 2. doi:10.1186/2051-5960-1-2 282 · DOI
- Wang W. et al. Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein //Proceedings of the National Academy of Sciences. -2016. -Т. 113. -№. 34
- Wirdefeldt K. et al. Epidemiology and etiology of Parkinson's disease: a review of the evidence //European journal of epidemiology. -2011. -Т. 26. -№. 1. -С. 1. doi:10.1007/s10654-011-9581-6 295 · DOI
- Yozgat Y. et al. Sphingomonas paucimobilis bacteraemia and shock in a patient with rheumatic carditis //Indian journal of medical microbiology. -2014. -Т. 32. -№.
- Yu G. et al. Molecular characterization of the human stomach microbiota in gastric cancer patients //Frontiers in cellular and infection microbiology. -2017. -Т. 7. -С. 302. doi: 10.3389/fcimb.2017.00302 301 · DOI
- Authors
- Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., Mironova, Y. S., Izhboldina, O. P., Nikitina, M. A., Perevozchikova, T. V., Fait, E. A., Babenko, V. V., Vakhitova, M. T., Govorun, V. M., & Sazonov, A. E.
- Affiliations
- Siberian State Medical University (RU)
- Federal Medical-Biological Agency (RU)
- Institute of Bioorganic Chemistry (RU)
- ORCID
- Venue
- Bulletin of Experimental Biology and Medicine
- Published
- 2017-04
- Volume
- 162
- Issue
- 6
- Pages
- 734-737
- ISSN
- 0007-4888 (ISSN-L)
- 1573-8221
- OpenAlex
- W2607019262
- Cited by
- 487
- References
- 14
- Citations by year
- 2026: 23 · 2025: 40 · 2024: 50 · 2023: 58 · 2022: 79 · 2021: 88 · 2020: 65 · 2019: 50 · 2018: 29 · 2017: 4 · 2016: 1
- FWCI
- 16.53
- Type
- journal article
- Language
- en
- Open access
- green
- orbi.uliege.be
- Licence
- Locations
- Bulletin of Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion, other-oa)
- ORBi (University of Liège) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Parkinson's disease, gut microbiota, gut-brain axis, alpha-synuclein aggregation, Lewy bodies, inflammation, 16S rRNA gene sequencing, bacterial genera, Lactobacillus, Oscillospira, Bacteroides, Prevotella, Ruminococcus
- MeSH terms
- Gastrointestinal Microbiome, Aged, DNA, Bacterial, Feces, Female, Gram-Negative Bacteria, Gram-Positive Bacteria, Humans, Male, Middle Aged, Parkinson Disease, Phylogeny, RNA, Ribosomal, 16S, Case-Control Studies, Sequence Analysis, DNA, Biodiversity, DNA Barcoding, Taxonomic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review